Biotechnology, Editors Pick, Latest News, Newsroom Nov 17th Merck’s Massive € 290 Million Investment in U.S. Drug Safety Testing is a Win for Consumers.
Biotechnology, Latest News, Newsroom Oct 13th Merck pays $250 million to Moderna to license the joint development of a cancer vaccine.
